Your shopping cart is currently empty

Fonsartan (HR720) is an AT1 receptor antagonist. It is utilized in research related to myocardial infarction (MI).
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Fonsartan (HR720) is an AT1 receptor antagonist. It is utilized in research related to myocardial infarction (MI). |
| In vitro | Fonsartan selectively inhibits the AT1 receptor, primarily located in the adrenal cortex, with an IC50 of 1.5 × 10^(-8) M, while exhibiting lower affinity for the AT2 receptor, mainly found in the adrenal medulla, with an IC50 of 1.4 × 10^(-6) M. |
| In vivo | When administered to rats in a myocardial infarction (MI) model, Fonsartan (3 mg/kg, subcutaneous injection, once daily for 6 weeks) provides the most comprehensive cardioprotective effects when treatment begins 3-24 hours post-modeling. |
| Synonyms | HR 720 |
| Molecular Weight | 620.87 |
| Formula | C26H30K2N4O5S2 |
| Cas No. | 153235-15-5 |
| Smiles | O=C(C1=C(SC)N=C(CCCC)N1CC2=CC=C(C3=C(S(=O)([N-]C(NCCC)=O)=O)C=CC=C3)C=C2)[O-].[K+].[K+] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.